{"entity":{"type":"insider","cik":"0001280564","url":"/insider/0001280564","json_url":"/insider/0001280564.json","name":"MEGLASSON MARTIN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2004-11-12","last":"2015-05-22","span_basis":"filed_date"},"name_variants":[{"name":"MEGLASSON MARTIN","source":"filing","n_filings":7,"first_seen":"2004-11-12","last_seen":"2015-05-22"}],"transactions":[{"id":8366526,"accession":"0001179110-15-008414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-008414","line_url":"/filing/0001179110-15-008414#line-1","is_derivative":false,"issuer_cik":"0001280564","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001280564","owner_cik":"0001280564","owner_name":"MEGLASSON MARTIN","owner_display_name":"MEGLASSON MARTIN","owner_url":"/insider/0001280564","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":712.0,"shares_display":"712","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":5980.8,"total_display":"5,980.80","total_whole":"5,981","shares_owned_after":19098.0,"shares_owned_after_display":"19,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-20","filed_date":"2015-05-22","scope":"insider"},{"id":8877015,"accession":"0001104659-15-013142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-013142","line_url":"/filing/0001104659-15-013142#line-1","is_derivative":false,"issuer_cik":"0001280564","issuer_name":"Bellerophon Therapeutics, Inc.","issuer_ticker":"BLPH","issuer_name_source":null,"issuer_url":"/issuer/0001280564","owner_cik":"0001280564","owner_name":"MEGLASSON MARTIN","owner_display_name":"MEGLASSON MARTIN","owner_url":"/insider/0001280564","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":144000.0,"total_display":"144,000.00","total_whole":"144,000","shares_owned_after":18386.0,"shares_owned_after_display":"18,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-19","filed_date":"2015-02-23","scope":"insider"},{"id":7739205,"accession":"0000886163-10-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-10-000041","line_url":"/filing/0000886163-10-000041#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001280564","owner_name":"MEGLASSON MARTIN","owner_display_name":"MEGLASSON MARTIN","owner_url":"/insider/0001280564","role":"Officer (V-P, Discovery Research)","role_mark":"O","role_mark_label":"Officer (V-P, Discovery Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V-P, Discovery Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":10187.5,"total_display":"10,187.50","total_whole":"10,188","shares_owned_after":102250.0,"shares_owned_after_display":"102,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-11","filed_date":"2010-05-11","scope":"insider"},{"id":3752755,"accession":"0000886163-08-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-08-000006","line_url":"/filing/0000886163-08-000006#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001280564","owner_name":"MEGLASSON MARTIN","owner_display_name":"MEGLASSON MARTIN","owner_url":"/insider/0001280564","role":"Officer (V-P, Discovery Research)","role_mark":"O","role_mark_label":"Officer (V-P, Discovery Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V-P, Discovery Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.359,"price_display":"3.36","price_state":"stated","total_value":10077.0,"total_display":"10,077.00","total_whole":"10,077","shares_owned_after":36500.0,"shares_owned_after_display":"36,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-09","filed_date":"2008-05-09","scope":"insider"},{"id":8442332,"accession":"0000886163-07-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-07-000135","line_url":"/filing/0000886163-07-000135","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001280564","owner_name":"MEGLASSON MARTIN","owner_display_name":"MEGLASSON MARTIN","owner_url":"/insider/0001280564","role":"Officer (V-P, Discovery Research)","role_mark":"O","role_mark_label":"Officer (V-P, Discovery Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V-P, Discovery Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.19306,"price_display":"6.19","price_state":"stated","total_value":12386.12,"total_display":"12,386.12","total_whole":"12,386","shares_owned_after":12888.0,"shares_owned_after_display":"12,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-08-30","scope":"insider","n_lines":2},{"id":4634012,"accession":"0000886163-06-000155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-06-000155","line_url":"/filing/0000886163-06-000155#line-2","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001280564","owner_name":"MEGLASSON MARTIN","owner_display_name":"MEGLASSON MARTIN","owner_url":"/insider/0001280564","role":"Officer (V-P, Discovery Research)","role_mark":"O","role_mark_label":"Officer (V-P, Discovery Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V-P, Discovery Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5313.0,"shares_display":"5,313","price_per_share":11.2283,"price_display":"11.23","price_state":"stated","total_value":59655.9579,"total_display":"59,655.96","total_whole":"59,656","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-15","filed_date":"2006-12-19","scope":"insider"},{"id":426040,"accession":"0001247741-04-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001247741-04-000095","line_url":"/filing/0001247741-04-000095#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001280564","owner_name":"MEGLASSON MARTIN","owner_display_name":"MEGLASSON MARTIN","owner_url":"/insider/0001280564","role":"Officer (V-P, Discovery Research)","role_mark":"O","role_mark_label":"Officer (V-P, Discovery Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V-P, Discovery Research","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.82,"price_display":"8.82","price_state":"stated","total_value":4410.0,"total_display":"4,410.00","total_whole":"4,410","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-11-11","filed_date":"2004-11-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001600132","name":"Bellerophon Therapeutics, Inc.","url":"/issuer/0001600132","role":"Officer (Chief Scientific Officer)","n_filings":2,"first_seen":"2015-02-23","last_seen":"2015-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Officer (V-P, Discovery Research)","n_filings":5,"first_seen":"2004-11-12","last_seen":"2010-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001280564","retrieved_at":"2026-08-25T17:52:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}